(180 days)
The Activator V-E is indicated for chiropractic adjustment of the spine and extremities. It is intended for external use only.
Not Found
The provided document is a 510(k) premarket notification letter from the FDA for a medical device called the "Activator V-E Spinal Adjusting Instrument." This letter confirms that the device is substantially equivalent to legally marketed predicate devices.
However, the document does not contain the kind of information typically associated with a study that proves a device meets acceptance criteria using performance metrics like accuracy, sensitivity, specificity, or F1-score. This type of information is usually found in detailed clinical study reports, scientific publications, or specific sections of a 510(k) submission that describe performance testing.
The 510(k) clearance process primarily focuses on demonstrating substantial equivalence to a predicate device, meaning the new device is as safe and effective as a legally marketed device. It does not necessarily require the presentation of novel clinical performance data demonstrating specific quantitative acceptance criteria in the same way a de novo application or a premarket approval (PMA) might.
Therefore, I cannot extract the requested information from this document. It does not contain:
- A table of acceptance criteria and reported device performance.
- Sample size for test sets or data provenance for performance studies.
- Number and qualifications of experts for ground truth establishment.
- Adjudication method for test sets.
- Results of a multi-reader multi-case (MRMC) comparative effectiveness study.
- Results of a standalone algorithm performance study.
- Type of ground truth used for such studies.
- Sample size or ground truth establishment for a training set (as this is not an AI/ML device document).
The document is purely a regulatory clearance letter acknowledging substantial equivalence based on information submitted previously by the manufacturer, but the letter itself does not detail the specific performance studies.
N/A